A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

Clinical trial NCT00502736 · COMPLETED

Trial details

NCT number: NCT00502736
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain; Bone Neoplasms; Neoplasm Metastasis

Start date: 2008-01-01
Primary completion: 2009-03-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.